Valuation: MedPacto, Inc.

Market Cap 9.63TCr 6.41Cr 5.61Cr 5.17Cr 4.78Cr 9.07Cr 611.74Cr 9.22Cr 62Cr 24Cr 301.36Cr 24Cr 24Cr 1.04TCr P/E 2024
-7.42x
P/E 2025 -17.9x
Enterprise Value 5.73TCr 3.82Cr 3.34Cr 3.08Cr 2.85Cr 5.4Cr 364.2Cr 5.49Cr 37Cr 14Cr 179.41Cr 14Cr 14Cr 616.79Cr EV / Sales 2024
-
EV / Sales 2025 4,87,33,025x
Free-Float
74%
Yield 2024 *
-
Yield 2025 -
1 day+1.08%
1 week-11.64%
Current month-10.65%
1 month-15.62%
3 months-45.65%
6 months-59.16%
Current year-57.93%
1 week 2,700
Extreme 2700
3,275
1 month 2,655
Extreme 2655
3,660
Current year 2,655
Extreme 2655
7,980
1 year 2,655
Extreme 2655
8,650
3 years 2,655
Extreme 2655
17,240
5 years 2,655
Extreme 2655
71,500
10 years 2,655
Extreme 2655
1,34,200
Manager TitleAgeSince
Chief Executive Officer 72 19/06/2013
President 66 28/03/2024
Corporate Officer/Principal 67 -
Director TitleAgeSince
Director/Board Member 72 19/06/2013
Director/Board Member 63 28/03/2024
Director/Board Member 74 28/03/2024
Date Insider Type Main position Quantity % Market Cap.
04/25/04Buy 10,000 0.0292%
04/25/04Buy

Chairperson

15,000 0.0438%
04/25/04Buy

Chairperson

15,000 0.0438%
Change 5-day change 1-year change 3-year change Capi.($)
+1.08%-11.64%-30.19%-80.50% 6.41Cr
-4.14%-8.06%+57.35%+117.24% 5.46TCr
+1.84%-0.66%+75.79%+93.87% 5.49TCr
-2.24%+3.59%+19.60%+466.72% 2.51TCr
-1.60%-6.21%-19.69%-14.84% 2.31TCr
+2.43%+1.06%+47.70%-0.11% 1.99TCr
-3.19%0.00%+33.99%-26.87% 1.75TCr
-6.84%+2.18%+195.12%+357.18% 1.65TCr
-1.05%+1.16%+25.08%+196.28% 1.42TCr
+8.74%+3.51%+53.81% - 1.54TCr
Average -0.50%-0.91%+45.86%+123.22% 2.41TCr
Weighted average by Cap. -0.91%-1.46%+55.02%+137.72%

Financials

2024 2025
Net sales - 3.9T 2.6 2.27 2.09 1.93 3.67 247.61 3.73 25.03 9.83 121.98 9.75 9.54 419.35
Net income -2.01TCr -1.34Cr -1.17Cr -1.08Cr -99.95L -1.9Cr -127.92Cr -1.93Cr -13Cr -5.08Cr -63Cr -5.04Cr -4.93Cr -216.64Cr -1.28TCr -85.31L -74.62L -68.83L -63.57L -1.21Cr -81Cr -1.23Cr -8.22Cr -3.23Cr -40Cr -3.2Cr -3.13Cr -137.8Cr
Net Debt -5.35TCr -3.57Cr -3.12Cr -2.88Cr -2.66Cr -5.04Cr -340.05Cr -5.13Cr -34Cr -13Cr -167.52Cr -13Cr -13Cr -575.89Cr -3.9TCr -2.6Cr -2.27Cr -2.09Cr -1.93Cr -3.67Cr -247.54Cr -3.73Cr -25Cr -9.83Cr -121.95Cr -9.75Cr -9.53Cr -419.22Cr
Logo MedPacto, Inc.
MedPacto, Inc. is a Korea-based company principally engaged in the research and development of biopharmaceuticals. The Company researches and develops anticancer drugs and diagnostic kits including vactosertib, MA-B2 and others. The products are used as the treatment of multiple myeloma, lung cancer, stomach cancer, colon cancer, blood cancer, triple negative breast cancer and pancreatic cancer, among others.
Employees
-
Date Price Change Volume
10/26/10 ₩2,810.00 +1.08% 1,66,440
09/26/09 ₩2,780.00 -1.77% 2,05,811
08/26/08 ₩2,830.00 -5.51% 2,28,612
07/26/07 ₩2,995.00 -0.50% 2,14,052
06/26/06 ₩3,010.00 -5.35% 1,40,667
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
CCC

Net sales - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A235980 Stock